메뉴 건너뛰기
.. 내서재 .. 알림
소속 기관/학교 인증
인증하면 논문, 학술자료 등을  무료로 열람할 수 있어요.
한국대학교, 누리자동차, 시립도서관 등 나의 기관을 확인해보세요
(국내 대학 90% 이상 구독 중)
로그인 회원가입 고객센터 ENG
주제분류

추천
검색

이용수

표지
📌
연구주제
📖
연구배경
🔬
연구방법
🏆
연구결과
AI에게 요청하기
추천
검색

초록· 키워드

오류제보하기
Background: Although allergen specific immunotherapy has been used as the only curative treatment for allergic diseases, there have been few studies that observed the efficacy of immunotherapy in asthmatics. Objective: We attempted to determine clinical parameters for predicting the remission of asthma after immunotherapy with house dust mite extracts. Method: Fifty-six adult asthmatic patients undergoing immunotherapy with house dust mite extracts for more than 3 years were enrolled. They were classified into the remitted and unremitted group according to the results of following methacholine challenge test. Skin reactivity, immunologic findings, spirometry, and airway hyperreactivity were compared between the 2 groups. Result: Twenty-six subjects (46.4%) were in the remitted group and 30 subjects (53.6%) were in the unremitted group. Both onset age of asthma symptoms and starting age of immunotherapy were significantly lower in the remitted group (P<0.05, for each). Baseline FEV1 levels and degree of airway hyperreactivity were significantly better in the remitted group (P<0.01 and 0.05, respectively). Conclusion: Younger age, earlier immunotherapy as well as better lung function and airway hyperreactivity at baseline can be used to predict the remission of asthma in adults. Therefore, earlier allergen immunotherapy in younger age group might help achieve remission in adult allergic asthma. (Korean J Asthma Allergy Clin Immunol 2007;27:257-262)

목차

등록된 정보가 없습니다.

참고문헌 (25)

참고문헌 신청

함께 읽어보면 좋을 논문

논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!

이 논문의 저자 정보

최근 본 자료

전체보기

댓글(0)

0